Health & Medicine
FDA Approves Drug to Treat Gastrointestinal Stromal Tumors
A new drug Stivarga has won the approval of the U.S. Food and Drug Administration to cure patients who are victims of advanced gastrointestinal stroma tumors (GIST) that cannot be removed surgically and have failed to respond to other FDA-approved treatments.
Latest Research Articles
Natural Antibiotic from Sweat can Fight TB Germs, Bugs: Study
Scientists Develop New Drug against Flu Virus
Exposure to Deet Makes Some Mosquitoes Less Sensitive to Repellent
Scientists Identify Brain Chemicals Behind Seals' Ability to Sleep With Half a Brain
Male Rat Pups have Higher Levels of Language Protein than Females
Living Organisms Need AntiFreeze Proteins to Survive in Cold
Smoking Ban Drastically Reduces Premature Birth
Neutering Causes Cancer and Joint Disease in Dogs
Stress does not Cause Cancer: Study
Scientists Develop Spectacle Lens to Cure Color Blindness
New Study Sheds Light on Spread of Sexually Transmitted Disease in Ladybirds
Vitamin D, Omega-3 May Help Clear Amyloid Plaques Found in Alzheimer's
MOST POPULAR
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
-
Undersea Volcano Off Oregon Coast Could Erupt in 2025 After Scientists Notice 'Swelling'
